Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | ISO | Klhl42 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of KLHL42 mRNA | CTD | PMID:22206623 | 17beta-estradiol | increases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | Estradiol results in increased expression of KLHL42 mRNA | CTD | PMID:31614463 | 2,2',5,5'-tetrachlorobiphenyl | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:23829299 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Klhl42 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of KLHL42 mRNA | CTD | PMID:19770486 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of KLHL42 mRNA | CTD | PMID:33387578 | 2-deoxy-D-glucose | increases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | Deoxyglucose results in increased expression of KLHL42 mRNA | CTD | PMID:33770205 | 2-methylcholine | affects expression | ISO | KLHL42 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of KLHL42 mRNA | CTD | PMID:21179406 | 3,4-methylenedioxymethamphetamine | decreases expression | EXP | | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of KLHL42 mRNA | CTD | PMID:30071829 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Klhl42 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of KLHL42 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of KLHL42 mRNA | CTD | PMID:24780913 | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of KLHL42 mRNA | CTD | PMID:31881176 | acrolein | multiple interactions | ISO | KLHL42 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of KLHL42 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of KLHL42 mRNA | CTD | PMID:32699268 | alpha-pinene | multiple interactions | ISO | KLHL42 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of KLHL42 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of KLHL42 mRNA | CTD | PMID:32699268 | arsenite(3-) | increases methylation | ISO | KLHL42 (Homo sapiens) | 6480464 | arsenite results in increased methylation of KLHL42 promoter | CTD | PMID:23974009 | atrazine | decreases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of KLHL42 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | increases expression | ISO | Klhl42 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of KLHL42 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | increases methylation | ISO | KLHL42 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of KLHL42 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of KLHL42 mRNA | CTD | PMID:22316170 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of KLHL42 mRNA | CTD | PMID:25181051 | bleomycin A2 | increases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | Bleomycin results in increased expression of KLHL42 mRNA | CTD | PMID:33770205 | butanal | decreases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of KLHL42 mRNA | CTD | PMID:26079696 | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of KLHL42 mRNA | CTD | PMID:19167457 | camptothecin | increases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | Camptothecin results in increased expression of KLHL42 mRNA | CTD | PMID:33770205 | chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of KLHL42 mRNA | CTD | PMID:23125180 | crocidolite asbestos | decreases methylation | ISO | KLHL42 (Homo sapiens) | 6480464 | Asbestos and Crocidolite results in decreased methylation of KLHL42 5' UTR | CTD | PMID:29523930 | CU-O LINKAGE | decreases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | cupric oxide results in decreased expression of KLHL42 mRNA | CTD | PMID:22077320 | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of KLHL42 mRNA | CTD | PMID:23914054 | dieldrin | decreases response to substance | ISO | KLHL42 (Homo sapiens) | 6480464 | KLHL42 gene mutant form results in decreased susceptibility to Dieldrin | CTD | PMID:32421776 | doxorubicin | decreases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of KLHL42 mRNA | CTD | PMID:29803840 | entinostat | decreases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | entinostat results in decreased expression of KLHL42 mRNA | CTD | PMID:27188386 | ethanol | affects splicing | ISO | Klhl42 (Mus musculus) | 6480464 | Ethanol affects the splicing of KLHL42 mRNA | CTD | PMID:30319688 | fluoranthene | multiple interactions | ISO | Klhl42 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of KLHL42 mRNA | CTD | PMID:28329830 | folic acid | decreases expression | ISO | Klhl42 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of KLHL42 mRNA | CTD | PMID:25629700 | genistein | affects expression | ISO | Klhl42 (Mus musculus) | 6480464 | Genistein affects the expression of KLHL42 mRNA | CTD | PMID:32186404 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of KLHL42 mRNA | CTD | PMID:22061828 and PMID:33387578 | HC toxin | decreases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | HC toxin results in decreased expression of KLHL42 mRNA | CTD | PMID:33770205 | maneb | multiple interactions | ISO | Klhl42 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of KLHL42 mRNA | CTD | PMID:36117858 | melphalan | increases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | Melphalan results in increased expression of KLHL42 mRNA | CTD | PMID:22363485 | methyl methanesulfonate | increases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of KLHL42 mRNA | CTD | PMID:23649840 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of KLHL42 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | KLHL42 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of KLHL42 mRNA more ... | CTD | PMID:32699268 | paracetamol | decreases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of KLHL42 mRNA | CTD | PMID:21420995 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of KLHL42 mRNA | CTD | PMID:33387578 | paraquat | multiple interactions | ISO | Klhl42 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of KLHL42 mRNA | CTD | PMID:36117858 | PCB138 | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:23829299 | rotenone | increases expression | ISO | Klhl42 (Mus musculus) | 6480464 | Rotenone results in increased expression of KLHL42 mRNA | CTD | PMID:32937126 | silicon dioxide | decreases expression | ISO | Klhl42 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of KLHL42 mRNA | CTD | PMID:19073995 and PMID:33720480 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of KLHL42 mRNA | CTD | PMID:25729387 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of KLHL42 mRNA | CTD | PMID:25729387 | trichostatin A | decreases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of KLHL42 mRNA | CTD | PMID:24935251 | trichostatin A | affects expression | ISO | KLHL42 (Homo sapiens) | 6480464 | trichostatin A affects the expression of KLHL42 mRNA | CTD | PMID:28542535 | trovafloxacin | increases expression | ISO | Klhl42 (Mus musculus) | 6480464 | trovafloxacin results in increased expression of KLHL42 mRNA | CTD | PMID:35537566 | urethane | increases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | Urethane results in increased expression of KLHL42 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of KLHL42 mRNA | CTD | PMID:19101580 and PMID:25716160 | valproic acid | affects expression | ISO | KLHL42 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of KLHL42 mRNA | CTD | PMID:25979313 | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of KLHL42 mRNA | CTD | PMID:19015723 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of KLHL42 mRNA | CTD | PMID:20566332 | vorinostat | decreases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of KLHL42 mRNA | CTD | PMID:27188386 | zinc atom | decreases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of KLHL42 mRNA | CTD | PMID:22171008 | zinc(0) | decreases expression | ISO | KLHL42 (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of KLHL42 mRNA | CTD | PMID:22171008 | |